MELANOMA, THE CURRENT STATE OF THE PROBLEM
DOI:
https://doi.org/10.30890/2567-5273.2024-34-00-023Keywords:
melanoma, ultraviolet radiation, MAPK, BRAF600, C-Kit, targeted therapy.Abstract
Background. Melanoma of the skin is one of the most dangerous forms of cancer, characterized by a high risk of recurrence and metastasis, and has an aggressive and unpredictable course. Although accounting for less than 10% of all skin malignancies, thisMetrics
References
Bono A, Tolomio E, Trincone S et al. Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter < or ¼ 3 mm. Br J Dermatol 2006; 155(3): 570–573.
Gershenwald JE, Scolyer RA, Hess KR et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; 67(6): 472–492.
Рак в Україні, 2019-2020. Бюлетень Національного канцер-реєстру № 22 - Київ, 2021.
Kittler, H., Pehamberger, H., Wolff, K., et al. (2002). Diagnostic accuracy of dermoscopy. The Lancet Oncology, 3(3), 159-165.
Mitra D., Luo X., Morgan A. et al. (2012) An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature, 491(7424): 449–453.
Garbe C., Amaral T., Peris K. et al. (2020b) European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment — Update 2019. Eur. J. Cancer, 126: 159–177.
Stolz W., Schiffner R., Burgdorf W.H.C. (2002) Dermatoscopy for facial pigmented skin lesions. Clinics in Dermatology, 20(3): 276–278.
Vuong K., Armstrong B.K., Drummond M. et al. (2020) Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines. Br. J. Dermatol., 182(5): 1262–1268.
Lee K.J., di Meo N., Yélamos O., Malvehy J. (2020) Dermoscopy/Confocal Microscopy for Melanoma Diagnosis. In: Cutaneous Melanoma, 145–194.
Gogas H., Eggermont A.M.M., Hauschild A. et al. (2009) Biomarkers in melanoma. Ann. Oncol., 20: 8–13.
Ruiter D.J., Spatz A., van den Oord J.J., Cook M.G. (2002) Pathologic staging of melanoma. Seminars in Oncology, 29(4): 370–381.
Valachis A., Ullenhag G.J. (2017) Discrepancy in BRAF status among patients with metastatic malignant melanoma: A meta-analysis. Eur. J. Cancer, 81: 106–115.
Elder D.E., Massi D., Scolyer R.A., Willemze R. (2018) WHO Classification of Skin Tumours. Fourth Edition.
Herraiz C., Garcia-Borron J.C., Jiménez-Cervantes C., Olivares C. (2017) MC1R signaling. Intracellular partners and pathophysiological implications. Biochim. Biophys. Acta Mol. Basis. Dis., 1863(10 Pt. A): 2448–2461.
Pizzichetta M.A., Talamini R., Stanganelli I. et al. (2004) Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br. J. Dermatol., 150(6): 1117–1124.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
